NDRA

Endra Life Sciences
$4.78
−$0.08 (−1.65%)Jul 27, 2026
0.3PoorMoatMint rating

MoatMint rates Endra Life Sciences (NDRA) 0.3 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.4 out of 10.

Key metrics

The numbers that frame NDRA today
Market cap
$6.07M
P/E (TTM)
-0.8
EV / FCF
-1.3
ROIC
-313.8%
Div yield
0%
Debt / equity
0.5
52wk Low
$2.96
52wk High
$9.85

NDRA stock rating

How NDRA scores on quality, value, growth, momentum and financial health
0.3out of 10
Low overallNeutral business, expensive priceTop 97% of ~5,000 US stocks
QualityPoor0.4/10
GrowthFair3.0/10
MomentumFair2.8/10
ValuePoor0.4/10
Financial HealthPoor1.0/10

Growth

Revenue and earnings trend for NDRA
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about NDRA
Is Endra Life Sciences a good buy?
No. Endra Life Sciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Endra Life Sciences is selling at a very high price.
What is the market capitalization of NDRA?
Endra Life Sciences's market capitalization is $6.07M.
What is the P/E ratio for NDRA stock?
Endra Life Sciences's current P/E ratio is -0.8.
What is the 52-week high for NDRA stock?
The 52-week high for Endra Life Sciences is $9.85. The current close of $4.78 is 51.5% below that high.
What is the 52-week low for NDRA stock?
The 52-week low for Endra Life Sciences is $2.96. The current close of $4.78 is 61.5% above that low.
Does NDRA stock pay dividends?
Endra Life Sciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NDRA?
Endra Life Sciences's Debt / Equity ratio is 0.53.